- Home
- UHT vs MGTX Comparison
UHT vs MGTX Comparison
Compare UHT & MGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | UHT | MGTX |
|---|---|---|
| Founded | 1986 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 593.0M | 610.1M |
| IPO Year | 1995 | 2018 |
Fundamental Metrics
Financial Performance| Metric | UHT | MGTX |
|---|---|---|
| Price | $40.88 | $7.62 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $26.00 |
| AVG Volume (30 Days) | 48.4K | ★ 308.2K |
| Earning Date | 04-27-2026 | 05-12-2026 |
| Dividend Yield | ★ 7.37% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 1.27 | N/A |
| Revenue | ★ $99,190,000.00 | $33,279,000.00 |
| Revenue This Year | $2.12 | N/A |
| Revenue Next Year | $2.94 | $569.48 |
| P/E Ratio | $31.95 | ★ N/A |
| Revenue Growth | 0.18 | ★ 137.42 |
| 52 Week Low | $35.26 | $4.73 |
| 52 Week High | $44.70 | $9.73 |
Technical Indicators
Market Signals| Indicator | UHT | MGTX |
|---|---|---|
| Relative Strength Index (RSI) | 36.55 | 52.69 |
| Support Level | $38.72 | $7.23 |
| Resistance Level | $41.64 | $8.15 |
| Average True Range (ATR) | 1.12 | 0.37 |
| MACD | -0.37 | 0.01 |
| Stochastic Oscillator | 27.59 | 78.71 |
Price Performance
Historical ComparisonAbout UHT Universal Health Realty Income Trust
Universal Health Realty Income Trust is a healthcare REIT. The company is engaged in the business of investing in and leasing healthcare and human service facilities through direct ownership or through joint ventures, which aggregate into a single reportable segment. The company actively manages a portfolio of healthcare and human service facilities. The revenue and net income are generated from the operation of the investment portfolio, located throughout the United States.
About MGTX MeiraGTx Holdings plc
MeiraGTx Holdings PLC is a clinical-stage gene therapy company. It focuses on the eye, salivary gland, and central nervous system disorders. The company's pipeline products include AAV-CNGB3, AAV-CNGA3 and AAV-RPGR, and others. Geographically, it operates in the United States, the United Kingdom, and European Union.